Archives

Loading Events

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)

Major depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.

1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1

2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.

Location

Larsen’s Grill Oxnard

590 Town Center Dr
Oxnard, California 93036 United States
+ Google Map
(805) 983-6600 View Venue Website

Featured Speakers

Marla Dallal

Marla Dallal, PharmD, RPH

Nephrology Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Marla Dallal, PharmD, RPH is a Clinical & Scientific Liaison at Otsuka Pharmaceutical Development and Commercialization covering Southern California. She earned her Doctor of Pharmacy degree from the University of Southern California, School of Pharmacy in Los Angeles. While in pharmacy school, Dr Dallal pursued various clinical internships within the acute care and ambulatory care settings at Cedars-Sinai Medical Center and Kaiser Permanente. Prior to joining Otsuka, Dr Dallal held various positions within Medical Affairs at Amgen Inc covering the cardiometabolic and nephrology therapeutic areas. She also served as a preceptor at Amgen Inc, where she instructed pharmacy students on Advanced Pharmacy Practice rotations. She is currently licensed as a pharmacist in the state of California with the National Association Board of Pharmacy.

Elika Hefazi

Elika Hefazi, PharmD, BCPP

Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

*Drs Dallal and Hefazi are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

Registration